Afroditi Boulougoura, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immune Reconstitution Inflammatory Syndrome | 3 | 2023 | 61 | 0.880 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2024 | 2163 | 0.690 |
Why?
|
Phosphofructokinases | 1 | 2022 | 6 | 0.220 |
Why?
|
Histoplasmosis | 1 | 2023 | 63 | 0.210 |
Why?
|
T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2021 | 2 | 0.190 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 232 | 0.180 |
Why?
|
Autoimmune Diseases | 2 | 2022 | 2248 | 0.160 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 285 | 0.160 |
Why?
|
HIV Infections | 3 | 2023 | 17347 | 0.140 |
Why?
|
Interleukin-17 | 1 | 2022 | 911 | 0.130 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 515 | 0.130 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2015 | 7 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2021 | 1870 | 0.130 |
Why?
|
Autoantibodies | 2 | 2023 | 2124 | 0.130 |
Why?
|
Glutamate Decarboxylase | 1 | 2015 | 239 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2199 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 917 | 0.110 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2010 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2023 | 3061 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7392 | 0.080 |
Why?
|
Kidney | 1 | 2023 | 7049 | 0.080 |
Why?
|
Autoimmunity | 2 | 2024 | 1355 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4525 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 251 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4549 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 12796 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3812 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1398 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 974 | 0.040 |
Why?
|
Th17 Cells | 1 | 2022 | 794 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1582 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1891 | 0.030 |
Why?
|
Humans | 9 | 2024 | 761423 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2015 | 147 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81509 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2015 | 279 | 0.030 |
Why?
|
Communicable Diseases | 1 | 2021 | 875 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.030 |
Why?
|
Multigene Family | 1 | 2015 | 1077 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3155 | 0.020 |
Why?
|
Autoantigens | 1 | 2015 | 892 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3381 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2023 | 4370 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2572 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168441 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11902 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2651 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3077 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2015 | 1346 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4575 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4575 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5036 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4650 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2831 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11526 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10762 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9995 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10194 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3441 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16979 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41446 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54415 | 0.010 |
Why?
|
Adult | 2 | 2021 | 221148 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59207 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80582 | 0.010 |
Why?
|
Male | 2 | 2021 | 360736 | 0.010 |
Why?
|
Female | 2 | 2021 | 392581 | 0.010 |
Why?
|
Aged | 1 | 2021 | 169235 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 220826 | 0.000 |
Why?
|